Cargando…
BPI-ANCA Provides Additional Clinical Information to Anti-Pseudomonas Serology: Results from a Cohort of 117 Swedish Cystic Fibrosis Patients
Patients with cystic fibrosis (CF) colonized with Pseudomonas aeruginosa (P. aeruginosa) have worse prognosis compared with patients who are not. BPI-ANCA is an anti-neutrophil cytoplasmic antibody against BPI (bactericidal/permeability increasing protein) correlating with P. aeruginosa colonization...
Autores principales: | Lindberg, Ulrika, Carlsson, Malin, Hellmark, Thomas, Segelmark, Mårten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4529961/ https://www.ncbi.nlm.nih.gov/pubmed/26273683 http://dx.doi.org/10.1155/2015/947934 |
Ejemplares similares
-
BPI-ANCA and Long-Term Prognosis among 46 Adult CF Patients: A Prospective 10-Year Follow-Up Study
por: Lindberg, Ulrika, et al.
Publicado: (2012) -
Clinical significance of BPI-ANCA in patients with cystic fibrosis: a single center prospective study
por: Iwuji, Kenneth, et al.
Publicado: (2023) -
Clinical significance of BPI‐ANCA detecting in COPD patients with Pseudomonas aeruginosa colonization
por: Tian, Yongjian, et al.
Publicado: (2019) -
Decreased Neutrophil Apoptosis in Quiescent ANCA-Associated Systemic Vasculitis
por: Abdgawad, Mohamed, et al.
Publicado: (2012) -
The Pathogenicity of BPI-ANCA in a Patient With Systemic Vasculitis
por: Takeda, Sayo, et al.
Publicado: (2019)